# Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Morphine

> **NCT04138615** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 44 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Morphine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04138615
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-12
- **Primary completion:** 2022-01-04
- **Final completion:** 2022-01-04
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04138615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04138615, "Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Morphine". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04138615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*